OrbiMed Advisors LLC's Form 4 filing
TELA Bio, Inc. (TELA) · filed Jul 2, 2024
- Accession no.
- 0000947871-24-000583
- Filed
- Jul 2, 2024, 4:54 PM ET
- Trade date
- Jun 28-Jul 2, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.02M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP IV LLCCIK 0001502240 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Common Stock | SSaleDisposed | −378,000 | $4.74 | −$1,791,720 | 2,457,542 | Indirect | |
| Jul 1, 2024 | Common Stock | SSaleDisposed | −13,700 | $4.68 | −$64,116 | 2,443,842 | Indirect | |
| Jul 2, 2024 | Common Stock | SSaleDisposed | −36,600 | $4.54 | −$166,164 | 2,407,242 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.